{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:02:47Z","timestamp":1788328967080,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012196","name":"James and Debbie Cho Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.nbd.2019.104537","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:41:56Z","timestamp":1566643316000},"page":"104537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Rational polytherapy in the treatment of cholinergic seizures"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-0517","authenticated-orcid":false,"given":"Jerome","family":"Niquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Suchomelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireri Betsabe Franco","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio de Araujo","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-9114","authenticated-orcid":false,"given":"Claude G.","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nbd.2019.104537_bb0005","first-page":"117","article-title":"Refractory status epilepticus","volume":"11","author":"Bleck","year":"2006","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.nbd.2019.104537_bb0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2019.104537_bb0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.nbd.2019.104537_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneumeth.2009.07.020","article-title":"Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study","volume":"184","author":"de Araujo Furtado","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"8","key":"10.1016\/j.nbd.2019.104537_bb0025","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1528-1167.2009.02478.x","article-title":"Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats","volume":"51","author":"de Araujo Furtado","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0030","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2019.104537_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tox.2007.02.012","article-title":"Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guineapigs","volume":"234","author":"Dorandeu","year":"2019","journal-title":"Toxicology"},{"issue":"Suppl. 9","key":"10.1016\/j.nbd.2019.104537_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12038","article-title":"GABAA receptor modulation by neurosteroids in models of temporal lobe epilepsies","volume":"53","author":"Ferando","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.nbd.2019.104537_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0006-8993(96)00203-X","article-title":"The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus","volume":"725","author":"Fujikawa","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0050","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0055","series-title":"Management of Status Epilepticus","first-page":"24","volume":"vol. 31","author":"Gezalian","year":"2014"},{"key":"10.1016\/j.nbd.2019.104537_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nbd.2019.104537_bb0065","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104537_bb0070","series-title":"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Guidance for Industry","year":"2005"},{"key":"10.1016\/j.nbd.2019.104537_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004691-199110000-00004","article-title":"Principles for transformation of scalp EEG from potential field into source distribution","volume":"8","author":"Hjorth","year":"1991","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.nbd.2019.104537_bb0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2019.104537_bb0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/epi.14482","article-title":"Mechanisms of status epilepticus: \u03b1-Amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptor hypothesis","volume":"59","author":"Joshi","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clon.2006.10.010","article-title":"Chemotherapy dosing part I: scientific basis for current practice and use of body surface area","volume":"19","author":"Kaestner","year":"2007","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.nbd.2019.104537_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0920-1211(90)90025-Q","article-title":"NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures","volume":"5","author":"Kapur","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0100","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104537_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/jn.1989.61.2.417","article-title":"Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition","volume":"61","author":"Kapur","year":"1989","journal-title":"J. Neurophysiol."},{"issue":"63","key":"10.1016\/j.nbd.2019.104537_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuro.2017.09.009","article-title":"Brief isoflurane administration as a post-exposure treatment for organophosphate poisoning","volume":"2017","author":"Krishnan","year":"2017","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2019.104537_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nbd.2009.10.019","article-title":"Vulnerability of postnatal hippocampal neurons to seizures varies regionally with their maturational stage","volume":"37","author":"Lopez-Meraz","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104537_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2019.104537_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-8993(98)00606-4","article-title":"Self-sustaining status epilepticus after brief electrical stimulation of the perforant path","volume":"801","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of somaninduced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.nbd.2019.104537_bb0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1059-1311(03)00028-1","article-title":"Oral ketamine in paediatric non-convulsive status epilepticus","volume":"12","author":"Mewasingh","year":"2003","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.nbd.2019.104537_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2019.104537_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-4886(87)90293-7","article-title":"Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats","volume":"97","author":"Morrisett","year":"1987","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.1016\/j.nbd.2019.104537_bb0160","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2019.104537_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2188\/jea.8.33","article-title":"Epidemiological study of sarin poisoning in Matsumoto City, Japan","volume":"8","author":"Nakajima","year":"1998","journal-title":"J. Epidemiol."},{"key":"10.1016\/j.nbd.2019.104537_bb0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.apha.2014.11.008","article-title":"Regulation of GABAARs by phosphorylation","volume":"72","author":"Nakamura","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"Suppl. 5","key":"10.1016\/j.nbd.2019.104537_bb0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1167.2005.01022.x","article-title":"GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation","volume":"46","author":"Naylor","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0185","series-title":"Synaptic Non-NMDA Currents Increase in Dentate Gyrus Granule Cells During Status Epilepticus","volume":"vol. 2005","author":"Naylor","year":"2005"},{"key":"10.1016\/j.nbd.2019.104537_bb0190","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104537_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.104537_bb0200","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2019.104537_bb0205","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2019.104537_bb0210","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia"},{"issue":"104","key":"10.1016\/j.nbd.2019.104537_bb0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"29","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"2\u20133","key":"10.1016\/j.nbd.2019.104537_bb0220","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-1211(99)00088-1","article-title":"A new model of chronic temporal lobe epilepsy induced by electrical stimulation of the amygdala in rat","volume":"38","author":"Nissinen","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0225","first-page":"853","article-title":"The use of body surface area as a criterion of drug dosage in cancer chemotherapy","volume":"18","author":"Pinkel","year":"1958","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.nbd.2019.104537_bb0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2019.104537_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.nbd.2019.104537_bb0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2019.104537_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ntt.2014.06.002","article-title":"Caramiphen edisylate as adjunct to standard therapy attenuates soman-induced seizures and cognitive deficits in rats","volume":"44","author":"Schultz","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"issue":"6","key":"10.1016\/j.nbd.2019.104537_bb0255","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2019.104537_bb0260","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"issue":"7","key":"10.1016\/j.nbd.2019.104537_bb0265","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"NETT investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.104537_bb0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1203\/01.pdr.0000196333.16608.30","article-title":"Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects","volume":"59","author":"Suchomelova","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2019.104537_bb0275","series-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.nbd.2019.104537_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with Isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharm. Exp. Therap."},{"issue":"2","key":"10.1016\/j.nbd.2019.104537_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.4346-07.2008","article-title":"Deficits in phosphorylation of GABA(A) receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus","volume":"28","author":"Terunuma","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104537_bb0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/0748233706th268oa","article-title":"Development of a rat pilocarpine model of seizure\/status epilepticus that mimics chemical warfare nerve agent exposure","volume":"22","author":"Tetz","year":"2006","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.nbd.2019.104537_bb0295","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans affairs status epilepticus cooperative study group [see comments]","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"S6","key":"10.1016\/j.nbd.2019.104537_bb0300","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1528-1157.2000.tb01572.x","article-title":"Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptides neuromodulators","volume":"41","author":"Wasterlain","year":"2000","journal-title":"Epilepsia"},{"issue":"7604","key":"10.1016\/j.nbd.2019.104537_bb0305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nbd.2019.104537_bb0310","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:15:32Z","timestamp":1760850932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119302050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":60,"alternative-id":["S0969996119302050"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104537","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational polytherapy in the treatment of cholinergic seizures","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104537"}}